17-Allylaminogeldanamycin
CAS: 75747-14-7
Ref. 3D-AA17307
1mg | 136.00 € | ||
2mg | 188.00 € | ||
5mg | 300.00 € | ||
10mg | 440.00 € | ||
25mg | 704.00 € |
Product Information
- 17-Demethoxy-17-(2-propenylamino)geldanamycinTelatinibTanespimycin17-AAG
- (4Z,6E,10E)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- (8R,9R,12R,13S,14R,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- (8S,9S,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- 17-(Allylamino)-17-demethoxygeldanamycin
- 17-(Allylamino)-17-desmethylgeldanamycin
- 17-(Allylamino)geldanamycin
- 17-Allylaminodemethoxygeldanamycin
- 17-Demethoxy-17-(2-propenylamino)geldanamycin
- 17-Demethoxy-17-allylaminogeldanamycin
- See more synonyms
- 17-N-Allylamino-17-demethoxygeldanamycin
- 17Aag
- 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv.
- A 8476
- Bms 722782
- Cp 127374
- Geldanamycin, 17-demethoxy-17-(2-propenylamino)-
- Kos 953
- NSC 330507
- Tanespimycin
17-AAG is the first clinically tested hsp90 inhibitor that exhibits antitumor activity. Its antitumor effects are documented in vivo for various animal models, including erbB2-dependent breast cancer, prostate cancer models, and melanoma.
Chemical properties
Technical inquiry about: 3D-AA17307 17-Allylaminogeldanamycin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.